These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2956747)

  • 1. Anti-atherogenic activity of the calcium channel blocker isradipine (PN-200-110): a novel effect on matrix synthesis independent of calcium channel blockade.
    Heider JG; Weinstein DB; Pickens CE; Lan S; Su CM
    Transplant Proc; 1987 Aug; 19(4 Suppl 5):96-101. PubMed ID: 2956747
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium antagonists in experimental atherosclerosis. Use-dependence of isradipine: a potential explanation for enhanced action in atherosclerotic animals and tissue selectivity.
    Hof RP; Rüegg UT
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):107S-113S. PubMed ID: 1826999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the antiatherogenic effects of isradipine and ramipril in cholesterol-fed rabbits: I. Effect on progression of atherosclerosis and endothelial dysfunction.
    Riezebos J; Vleeming W; Beems RB; van Amsterdam JG; Meijer GW; de Wildt DJ; Porsius AJ; Wemer J
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):415-23. PubMed ID: 7515985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of calcium antagonists on total calcium and magnesium levels in the aorta of rabbits after administration of dietary cholesterol].
    Drábková E; Lazarová Z; Edelsteinová S; Czirfusz A; Gratzlová J; Holub P
    Cas Lek Cesk; 1992 Mar; 131(5):146-8. PubMed ID: 1581945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium blockers: antiatherogenic action by influencing the prostaglandin-system.
    Weiss K; Fitscha P; Gazsó A; Gludovacz D; Sinzinger H
    Prog Clin Biol Res; 1989; 301():353-7. PubMed ID: 2529552
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative hemodynamic studies of isradipine and dihydralazine in atherosclerotic and normal rabbits.
    Hof RP; Hof A; Takiguchi Y
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S13-22. PubMed ID: 1695297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-atherosclerotic and plasma lipid lowering effects of the novel calcium blocker with alpha 1-adrenoceptor antagonistic activity, monatepil, in high cholesterol diet-fed Japanese Macaca fuscata monkeys.
    Miyazaki M; Hosoki K; Okunishi H; Ishii K; Ikeno A; Okazaki Y
    Arzneimittelforschung; 1994 Mar; 44(3):288-97. PubMed ID: 8192692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of two calcium channel blockers--nifedipine and diltiazem--on atherogenesis in hypercholesterolemic hamster.
    Raicu M; Pojoga L; Simionescu N; Simionescu M
    J Submicrosc Cytol Pathol; 1996 Apr; 28(2):265-75. PubMed ID: 8964051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Do calcium antagonists inhibit the development of arteriosclerosis?].
    Liszewska-Pfejfer D; Skarzyńska M
    Kardiol Pol; 1992 Aug; 37(8):108-12. PubMed ID: 1434326
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the antiatherogenic effects of isradipine and ramipril in cholesterol-fed rabbits: II. Effect on regression of atherosclerosis and restoration of endothelial function.
    Riezebos J; Vleeming W; Beems RB; van Amsterdam JG; Meijer GW; de Wildt DJ; Porsius AJ; Wemer J
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):424-31. PubMed ID: 7515986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbit by treatment with the calcium blocker PN 200110.
    Habib JB; Bossaller C; Wells S; Williams C; Morrisett JD; Henry PD
    Circ Res; 1986 Feb; 58(2):305-9. PubMed ID: 2936528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct antiatherogenic activity of isradipine and lacidipine on neointimal lesions induced by perivascular manipulation in rabbits.
    Donetti E; Fumagalli R; Paoletti R; Soma MR
    Pharmacol Res; 1997 May; 35(5):417-22. PubMed ID: 9299204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylflavonolamine protects aorta from atherosclerosis in cholesterol-fed rabbits.
    Zhang MS; Zhou EF; Wang MZ; Li XM
    Zhongguo Yao Li Xue Bao; 1993 Mar; 14(2):133-6. PubMed ID: 8352005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ACE inhibitors on atheroma formation is potentiated by association with a calcium channel blocker. A biochemical and ultrastructural study.
    Raicu M; Pojoga L; Simionescu N; Simionescu M
    J Submicrosc Cytol Pathol; 1997 Jul; 29(3):317-28. PubMed ID: 9267040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium antagonists suppress atherogenesis in aorta but not in the intramural coronary arteries of cholesterol-fed rabbits.
    Ginsburg R; Davis K; Bristow MR; McKennett K; Kodsi SR; Billingham ME; Schroeder JS
    Lab Invest; 1983 Aug; 49(2):154-8. PubMed ID: 6876744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of isradipine on the formation and regression of fatty streaks in cholesterol fed rabbits.
    Kunjara-Na-Ayudhya R; Thomson AB; Kappagoda CT
    Cardiovasc Res; 1994 Jul; 28(7):1089-95. PubMed ID: 7954596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant aspirin treatment abolishes the antiatherosclerotic effects of the calcium channel blocker isradipine mediated by PGI2.
    Pirich C; Lupattelli G; Virgolini I; Keiler A; Gerakakis A; Angelberger P; Sinzinger H
    Agents Actions Suppl; 1992; 37():242-50. PubMed ID: 1385925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium antagonists and atherosclerosis.
    Betz E; Weiss HD; Heinle H; Fotev Z
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S71-5. PubMed ID: 1725009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isradipine inhibits mitotic and proliferative activity in the arterial wall.
    Fitscha P; Rauscha F; O'Grady J; Keiler A; Sinzinger H
    Exp Toxicol Pathol; 1994 Mar; 46(1):75-80. PubMed ID: 8086791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental arteriosclerosis in Wistar rats given a low-protein diet].
    Giannini SD; Sanchis FS; Cury CG
    Arq Bras Cardiol; 1980 Jul; 35(1):47-51. PubMed ID: 6971637
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.